Management of Hot Flashes in Young Women on Hormonal Contraceptives

Initial Treatment Strategy

• The American College of Obstetricians and Gynecologists recommends optimizing the gabapentin dose to 900 mg/day as first-line therapy for hot flashes in young women on hormonal contraceptives, providing dual benefit for both seizure control and hot flash management without adding additional medications 1, 2
• Gabapentin at 900 mg/day reduces hot flash severity by 46% compared to 15% with placebo, according to the Journal of the National Comprehensive Cancer Network 1, 2

Alternative Treatment Options

• The National Comprehensive Cancer Network recommends venlafaxine as an alternative option, starting at 37.5 mg/day and increasing to 75 mg/day after 1 week, which reduces hot flash frequency and severity by 61% at 75 mg/day compared to 27% with placebo 1, 4
• Paroxetine 12.5 mg/day reduces hot flash composite score by 62%, with no significant difference between 12.5 mg and 25 mg doses 1

Non-Pharmacologic Interventions

• Weight loss if overweight/obese can reduce hot flash symptoms, according to Praxis Medical Insights 3
• Cognitive behavioral therapy may help manage hot flashes and could provide additional benefit for PTSD, as recommended by Praxis Medical Insights 3

Clinical Pitfalls to Avoid

• The American College of Obstetricians and Gynecologists advises against adding estrogen therapy in young patients without thorough evaluation of why they're having hot flashes, as this is not typical menopause 1
• The National Comprehensive Cancer Network recommends monitoring for serotonin syndrome if adding SNRIs/SSRIs to a patient potentially on other psychotropic medications for psychiatric conditions 4
• Reassessing treatment at 4 weeks is crucial, as if no improvement is seen by this time, the treatment is unlikely to be effective and should be changed, according to Praxis Medical Insights 2, 5